Literature DB >> 11238554

MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.

J N Blankson1, R F Siliciano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11238554      PMCID： PMC199437          DOI： 10.1172/JCI12430

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

1.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.

Authors:  P J Goulder; R E Phillips; R A Colbert; S McAdam; G Ogg; M A Nowak; P Giangrande; G Luzzi; B Morgan; A Edwards; A J McMichael; S Rowland-Jones
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

2.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  Influence of HLA alleles on the rate of progression of vertically transmitted HIV infection in children: association of several HLA-DR13 alleles with long-term survivorship and the potential association of HLA-A*2301 with rapid progression to AIDS. Long-Term Survivor Study.

Authors:  Y Chen; R Winchester; B Korber; J Gagliano; Y Bryson; C Hutto; N Martin; G McSherry; A Petru; D Wara; A Ammann
Journal:  Hum Immunol       Date:  1997-07       Impact factor: 2.850

4.  Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.

Authors:  D A Price; P J Goulder; P Klenerman; A K Sewell; P J Easterbrook; M Troop; C R Bangham; R E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.

Authors:  U Malhotra; S Holte; S Dutta; M M Berrey; E Delpit; D M Koelle; A Sette; L Corey; M J McElrath
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

6.  Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection.

Authors:  U Malhotra; M M Berrey; Y Huang; J Markee; D J Brown; S Ap; L Musey; T Schacker; L Corey; M J McElrath
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

7.  Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.

Authors:  J N Blankson; J E Gallant; R F Siliciano
Journal:  J Infect Dis       Date:  2001-01-12       Impact factor: 5.226

8.  Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.

Authors:  P J Goulder; M Bunce; P Krausa; K McIntyre; S Crowley; B Morgan; A Edwards; P Giangrande; R E Phillips; A J McMichael
Journal:  AIDS Res Hum Retroviruses       Date:  1996-12-10       Impact factor: 2.205

9.  Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.

Authors:  R A Kaslow; M Carrington; R Apple; L Park; A Muñoz; A J Saah; J J Goedert; C Winkler; S J O'Brien; C Rinaldo; R Detels; W Blattner; J Phair; H Erlich; D L Mann
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

10.  Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor.

Authors:  D Schwartz; U Sharma; M Busch; K Weinhold; T Matthews; J Lieberman; D Birx; H Farzedagen; J Margolick; T Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  1994-12       Impact factor: 2.205
View more
  2 in total

1.  Human Immunotypes Impose Selection on Viral Genotypes Through Viral Epitope Specificity.

Authors:  Migle Gabrielaite; Marc Bennedbæk; Adrian G Zucco; Christina Ekenberg; Daniel D Murray; Virginia L Kan; Giota Touloumi; Linos Vandekerckhove; Dan Turner; James Neaton; H Clifford Lane; Sandra Safo; Alejandro Arenas-Pinto; Mark N Polizzotto; Huldrych F Günthard; Jens D Lundgren; Rasmus L Marvig
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 5.226

2.  Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.

Authors:  Koen K A Van Rompay; Jeffrey A Johnson; Emily J Blackwood; Raman P Singh; Jonathan Lipscomb; Timothy B Matthews; Marta L Marthas; Niels C Pedersen; Norbert Bischofberger; Walid Heneine; Thomas W North
Journal:  Retrovirology       Date:  2007-04-06       Impact factor: 4.602
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.